Feb 14 (Reuters) - India’s largest drugmaker Sun Pharmaceutical Industries Ltd reported on Wednesday a 75 percent drop in net profit in the quarter ending Dec. 31, well below analysts’ estimates.
Net profit fell to 3.65 billion rupees ($57 million) in the firm's third quarter from 14.72 billion rupees a year earlier, the company said. bit.ly/2Cn6Ve0
That compared with the 9.12 billion rupees average profit estimate of 17 analysts, Thomson Reuters data showed.
Total revenue from operations fell 16 percent to 66.53 billion rupees. ($1 = 64.0800 Indian rupees) (Reporting by Jessica Kuruthukulangara in Bengaluru; Editing by Edmund Blair)